Afinitor and Ear popping - a phase IV clinical study of FDA data

Summary:

Ear popping is reported only by a few people who take Afinitor.

The phase IV clinical study analyzes which people take Afinitor and have Ear popping. It is created by eHealthMe based on reports of 39,807 people who have side effects while taking Afinitor from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jan, 28, 2023

39,807 people reported to have side effects when taking Afinitor.
Among them, 1 person (0.0%) has Ear popping.

What is Afinitor?

Afinitor has active ingredients of everolimus. It is often used in breast cancer metastatic. eHealthMe is studying from 39,878 Afinitor users for its effectiveness, alternative drugs and more.

What is Ear popping?

Ear popping is found to be associated with 928 drugs and 569 conditions by eHealthMe.

Number of Afinitor and Ear popping reports submitted per year:

Gender of people who have Ear popping when taking Afinitor *:

female: 100 %
male: 0.0 %

Age of people who have Ear popping when taking Afinitor *:

Common drugs people take besides Afinitor *:

Common side effects people have besides Ear popping *:

Weight Decreased: 1 person, 100.00%
Cough: 1 person, 100.00%
Head Injury: 1 person, 100.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 100.00%
Gallbladder Disorder: 1 person, 100.00%
Fever: 1 person, 100.00%
Femur Fracture: 1 person, 100.00%
Fatigue (feeling of tiredness): 1 person, 100.00%
Fall: 1 person, 100.00%
Fainting (loss of consciousness and postural tone): 1 person, 100.00%

Common conditions people have *:

Postmenopause: 1 person, 100.00%
Pancreatic Neuroendocrine Tumor: 1 person, 100.00%
Osteoporosis (bones weak and more likely to break): 1 person, 100.00%
Osteopenia (a condition where bone mineral density is lower than normal): 1 person, 100.00%
Bone Density Decreased: 1 person, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Afinitor and have Ear popping?

Check whether Ear popping is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Ear popping and when was it recovered:

Ear popping in Afinitor

Expand to all the drugs that have ingredients of everolimus:

Ear popping and drugs with ingredients of everolimus

Alternative drugs to, pros and cons of Afinitor:

Afinitor (39,878 reports)

Common Afinitor side effects:

Death: 5,716 reports
Fatigue (feeling of tiredness): 4,180 reports
Diarrhea: 3,836 reports
Breathing difficulty: 2,776 reports
Rashes (redness): 2,725 reports
Pneumonia: 2,409 reports

Browse all side effects of Afinitor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Ear popping treatments and more:

Ear popping (1,367 reports)

COVID vaccines that are related to Ear popping:

Common drugs associated with Ear popping:

Fosamax: 298 reports
Zofran: 174 reports
Zometa: 169 reports
Aspirin: 103 reports

All the drugs that are associated with Ear popping:

Ear popping (928 drugs)

Common conditions associated with Ear popping:

Osteoporosis: 264 reports
High blood pressure: 112 reports

All the conditions that are associated with Ear popping:

Ear popping (569 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on everolimus (the active ingredients of Afinitor) and Afinitor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.